Browse by author
Lookup NU author(s): Professor Moein MoghimiORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2015 Elsevier Inc. The accumulation of extracellular amyloid-beta (Aβ) peptide and intracellular neurofibrillary tangles in the brain are two major neuropathological hallmarks of Alzheimer's disease (AD). It is thought that an equilibrium exists between Aβ in the brain and in the peripheral blood and thus, it was hypothesized that shifting this equilibrium towards the blood by enhancing peripheral clearance might reduce Aβ levels in the brain: the 'sink effect'. We tested this hypothesis by intraperitoneally injecting APP/PS1 transgenic mice with small unilamellar vesicles containing either phosphatidic acid or cardiolipin over 3. weeks. This treatment reduced significantly the amount of Aβ in the plasma and the brain levels of Aβ were lighter affected. Nevertheless, this dosing regimen did modulate tau phosphorylation and glycogen synthase kinase 3 activities in the brain, suggesting that the targeting of circulating Aβ may be therapeutically relevant in AD.
Author(s): Ordonez-Gutierrez L, Re F, Bereczki E, Ioja E, Gregori M, Andersen AJ, Anton M, Moghimi SM, Pei J-J, Masserini M, Wandosell F
Publication type: Article
Publication status: Published
Journal: Nanomedicine: Nanotechnology, Biology and Medicine
Year: 2015
Volume: 11
Issue: 2
Pages: 421-430
Print publication date: 01/02/2015
Online publication date: 14/11/2014
Acceptance date: 28/09/2014
ISSN (print): 1549-9634
ISSN (electronic): 1549-9642
Publisher: Elsevier Inc.
URL: https://doi.org/10.1016/j.nano.2014.09.015
DOI: 10.1016/j.nano.2014.09.015
PubMed id: 25461285
Altmetrics provided by Altmetric
